Pyrazine kinase inhibitors

Details for Australian Patent Application No. 2006279376 (hide)

Owner Vertex Pharmaceuticals Incoporated

Inventors Golec, Julian M.C.; Mortimore, Michael

Agent Cullens

Pub. Number AU-B-2006279376

PCT Pub. Number WO2007/022384

Priority 60/720,596 26.09.05 US; 60/709,541 18.08.05 US; 60/709,760 19.08.05 US

Filing date 17 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 14 April 2011

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/497 (2006.01)

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/022384 Priority application(s): WO2007/022384

14 April 2011 Application Accepted

  Published as AU-B-2006279376

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006279395-Ocular gene therapy using avalanchemediated transfection

2006279372-Bis-aryl amide compounds and methods of use